Peritoneal Nebulization of Ropivacaine for Postoperative Pain Control After Laparoscopic Cholecystectomy

NCT01143025 Phase 3 COMPLETED

The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 50 mg, 100 mg or 150 mg may prevent the use of morphine during the first day after laparoscopic cholecystectomy.

Details

Lead sponsor	San Gerardo Hospital
Phase	Phase 3
Status	COMPLETED
Enrolment	165
Start date	2010-03
Completion	2011-05

Conditions

• Laparoscopic Cholecystectomy

Interventions

• Ropivacaine 50 mg
• Ropivacaine 100 mg
• Ropivacaine 150 mg

Primary outcomes

• Morphine consumption (mg) — Up to 48 hours
  The total dose of morphine at every evaluation after awakening will be quantified using the PACU clinical chart and/or PCA infusers memory display

Countries

Italy